INTERACTIONS AFFECTING PHENYTOIN INTESTINAL

影响苯妥英肠的相互作用

基本信息

  • 批准号:
    3476721
  • 负责人:
  • 金额:
    $ 8.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1987
  • 资助国家:
    美国
  • 起止时间:
    1987-04-01 至 1992-03-31
  • 项目状态:
    已结题

项目摘要

The objective of the proposed research is to determine the extent to which coadministered glucose and calcium affect the intestinal absorption of the orally administered anticonvulsant, phenytoin, from solution. Phenytoin possesses a narrow therapeutic range and minor blood level fluctuations can result in dramatic clincial effects with respect to insufficient activity or effective overdosage. While the drug is well absorbed from solution, its poor dissolution and interactions with coadministered substances in the gastrointestinal (GI) tract can significantly affect its absorption. Two of these substances (glucose and calcium) apear to affect interactions at the intestinal membrane from phenytoin solution. Several reports in the literature and preliminary data obtained for this proposal indicate that these interactions are other than effects on solubility. Phenytoin's long-range side effects include changes in glucose and calcium homeostasis. Its mechanism of action in excitable cells appears to involve the drug's binding to membrane protein channels controlling cellular ion transport (specifically sodium and calcium). This binding is enhanced in depolarized cells including those in epileptic foci. The existence of similar membrane proteins involved in nutrient- ion cotransport in the leaky epithelia of the small intestine and ion transport in the tight epithelia of the large intestine suggests phenytoin binding in the GI tract. The extent of this binding will be affected by nutrient and ion transport-induced depolarization of enterocytes. Thus the presentation in the intestinal lumen of certain coadministered nutrients and ions are suspected of altering phenytoin's binding to these intestinal transport proteins resulting in drug absorption effects through a parallel pathway. Isolation of this phenomenon will be done experimentally through rat intestinal perfusion studies since this degree of isolation could most directly link the interaction to clinical significance. However, more isolated in vitro studies including intestinal ring uptake, voltage clamping, and possbily brush-border and inside-out basolateral membrane vesicles as well as isolated cell suspensions may be required to uncouple those ion trnasport processes effecting phenytoin membrane transport. In vivo dog experiments will be used to separate solubility effects from solution- membrane interactions.
拟议研究的目的是确定的程度

项目成果

期刊论文数量(7)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Phenytoin interaction with enteral feedings administered through nasogastric tubes.
苯妥英与通过鼻胃管进行肠内喂养的相互作用。
Intestinal water and solute absorption studies: comparison of in situ perfusion with chronic isolated loops in rats.
肠道水和溶质吸收研究:大鼠体内原位灌注与慢性隔离环的比较。
  • DOI:
    10.1023/a:1015848815616
  • 发表时间:
    1992
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Lu,HH;Thomas,JD;Tukker,JJ;Fleisher,D
  • 通讯作者:
    Fleisher,D
Colonic absorption of antiepileptic agents.
抗癫痫药的结肠吸收。
  • DOI:
    10.1111/j.1528-1157.1997.tb01078.x
  • 发表时间:
    1997
  • 期刊:
  • 影响因子:
    5.6
  • 作者:
    Stevenson,CM;Kim,J;Fleisher,D
  • 通讯作者:
    Fleisher,D
The intestinal uptake of "enzymatically-stable" peptide drugs in rats as influenced by D-glucose in situ.
大鼠肠道对“酶稳定”肽药物的摄取受原位 D-葡萄糖的影响。
  • DOI:
    10.1016/0024-3205(94)90132-5
  • 发表时间:
    1994
  • 期刊:
  • 影响因子:
    6.1
  • 作者:
    Hu,Z;Tse,EG;Monkhouse,DC;Oh,CK;Fleisher,D
  • 通讯作者:
    Fleisher,D
CCK antagonist pre-treatment inhibits meal-enhanced drug absorption in dogs.
CCK 拮抗剂预处理可抑制狗的膳食增强药物吸收。
  • DOI:
    10.1016/s0167-0115(96)00128-0
  • 发表时间:
    1997
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Miles,C;Dickson,P;Rana,K;Lippert,C;Fleisher,D
  • 通讯作者:
    Fleisher,D
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID FLEISHER其他文献

DAVID FLEISHER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID FLEISHER', 18)}}的其他基金

INTESTINAL CLEARANCE--MECHANISMS & PLASMA LEVEL EFFECTS
肠道清除——机制
  • 批准号:
    2415237
  • 财政年份:
    1996
  • 资助金额:
    $ 8.21万
  • 项目类别:
INTESTINAL CLEARANCE--MECHANISMS & PLASMA LEVEL EFFECTS
肠道清除——机制
  • 批准号:
    2701617
  • 财政年份:
    1996
  • 资助金额:
    $ 8.21万
  • 项目类别:
INTESTINAL CLEARANCE--MECHANISMS & PLASMA LEVEL EFFECTS
肠道清除——机制
  • 批准号:
    2189039
  • 财政年份:
    1996
  • 资助金额:
    $ 8.21万
  • 项目类别:
INTESTINAL ABSORPTION/METABOLISM OF H2 ANTAGONISTS
H2 拮抗剂的肠道吸收/代谢
  • 批准号:
    2189038
  • 财政年份:
    1995
  • 资助金额:
    $ 8.21万
  • 项目类别:
INTERACTIONS AFFECTING PHENYTOIN INTESTINAL
影响苯妥英肠的相互作用
  • 批准号:
    3476718
  • 财政年份:
    1987
  • 资助金额:
    $ 8.21万
  • 项目类别:
INTERACTIONS AFFECTING PHENYTOIN INTESTINAL
影响苯妥英肠的相互作用
  • 批准号:
    3476717
  • 财政年份:
    1987
  • 资助金额:
    $ 8.21万
  • 项目类别:
INTERACTIONS AFFECTING PHENYTOIN INTESTINAL
影响苯妥英肠的相互作用
  • 批准号:
    3476719
  • 财政年份:
    1987
  • 资助金额:
    $ 8.21万
  • 项目类别:
INTERACTIONS AFFECTING PHENYTOIN INTESTINAL
影响苯妥英肠的相互作用
  • 批准号:
    3476720
  • 财政年份:
    1987
  • 资助金额:
    $ 8.21万
  • 项目类别:

相似海外基金

Molecular mechanism for targeting of NCX1 to basolateral membrane in renal epithelial cells
NCX1靶向肾上皮细胞基底外侧膜的分子机制
  • 批准号:
    23590319
  • 财政年份:
    2011
  • 资助金额:
    $ 8.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of microdomain of the apical and basolateral membrane in epithelial cells with polarity
上皮细胞顶、基底外侧膜极性微区分析
  • 批准号:
    21590209
  • 财政年份:
    2009
  • 资助金额:
    $ 8.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
POWRE: The Evolving Function of the Basolateral Membrane Ca Pump in Exchange Epithelia of a Continuum of Aquatic to Semi-Terrestrial Brazilian Crabs
POWRE:水生到半陆生巴西蟹连续体交换上皮细胞中基底外侧膜钙泵的进化功能
  • 批准号:
    9870374
  • 财政年份:
    1998
  • 资助金额:
    $ 8.21万
  • 项目类别:
    Standard Grant
TARGETING ALPHA2 RECEPTORS TO RENAL BASOLATERAL MEMBRANE
将 ALPHA2 受体靶向肾基底外侧膜
  • 批准号:
    2143364
  • 财政年份:
    1993
  • 资助金额:
    $ 8.21万
  • 项目类别:
TARGETING ALPHA-2 RECEPTOR TO RENAL BASOLATERAL MEMBRANE
将 ALPHA-2 受体靶向肾基底外侧膜
  • 批准号:
    3245395
  • 财政年份:
    1993
  • 资助金额:
    $ 8.21万
  • 项目类别:
TARGETING ALPHA2 RECEPTORS TO RENAL BASOLATERAL MEMBRANE
将 ALPHA2 受体靶向肾基底外侧膜
  • 批准号:
    2143365
  • 财政年份:
    1993
  • 资助金额:
    $ 8.21万
  • 项目类别:
TARGETING ALPHA2 RECEPTORS TO RENAL BASOLATERAL MEMBRANE
将 ALPHA2 受体靶向肾基底外侧膜
  • 批准号:
    2143363
  • 财政年份:
    1993
  • 资助金额:
    $ 8.21万
  • 项目类别:
BASOLATERAL MEMBRANE POTASSIUM CHANNELS
基底外侧膜钾通道
  • 批准号:
    2144459
  • 财政年份:
    1992
  • 资助金额:
    $ 8.21万
  • 项目类别:
BASOLATERAL MEMBRANE POTASSIUM CHANNELS
基底外侧膜钾通道
  • 批准号:
    6176603
  • 财政年份:
    1992
  • 资助金额:
    $ 8.21万
  • 项目类别:
BASOLATERAL MEMBRANE POTASSIUM CHANNELS
基底外侧膜钾通道
  • 批准号:
    3246763
  • 财政年份:
    1992
  • 资助金额:
    $ 8.21万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了